CLX Stock Analysis — Clorox
Sector: Consumer Staples
AI Verdict
Clorox trades at 16.2x next year’s earnings while analysts expect a 31.7% rebound, so you’re getting a cheap price for a recovery story—if its brand-driven moat helps it deliver on those expectations.
Competitive Moat
Clorox owns dominant household cleaning and disinfectant brands, giving it shelf space and pricing power in supermarkets and big-box retailers. Its moat is reinforced by consumer habit, brand trust, and distribution relationships that are hard for new entrants to replicate.
Summary
Clorox is trading at a discount to its historical valuation as the market waits for a rebound in earnings after last year’s supply chain disruptions.
Where It Stands
Clorox has a -13.26% 1-year return, trades at 16.2x next year’s earnings versus the sector median of 20x, and is priced for a 31.7% EPS rebound.
Key Metrics
- Trailing P/E: 21.3x
- Forward P/E: 16.2x
- PEG Ratio: 0.63
- Earnings Growth: +0.3%
- Revenue Growth: -0.1%
- Market Cap: $12.4B
- Dividend Yield: 0.03%
- 1-Year Return: -13.26%
- 52-Week High: $128.90
- 52-Week Low: $84.70
Analyst Consensus
1 Buy · 17 Hold · 9 Sell (27 analysts)
Bull Case
With forward EPS growth of 31.7% and a forward P/E of 16.2x, you’re getting a big earnings jump at a cheaper multiple than most consumer staples stocks.
Bear Case
If the forward P/E reverts to the sector median of 20x without delivering the 31.7% EPS growth, investors could see little upside or even further downside after a -13.26% 1-year return.
Catalyst to Watch
Watch quarterly earnings for confirmation that supply chain normalization is translating into the forecasted 31.7% EPS growth.